Christy Kuo Bio

Dr. Kuo joined Avego in 2024 with a focus on biotech therapeutic companies at pre-clinical and clinical stages. Dr. Kuo’s life sciences industry experience includes various roles – as an investor, a drug developer, and a translational scientist. Prior to joining Avego, she was at RA Capital, working on both public and private investments, as well as serving on boards and as a scientific advisor. Previously, she was a drug developer at Pfizer, where she led oncology drug discovery projects to enable portfolio transitions to lead optimizations or IND enabling studies across small and large molecules. She began her career as a translational scientist at Memorial Sloan-Kettering Cancer Center, where she worked to optimize allogeneic T-cell therapies for transplant patients suffering from viral infections. Dr. Kuo received a Ph.D. in Immunology from Weill Cornell Medical College.